(NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura.
about
New strategies for BMT, organ transplantation, and regeneration therapy.Genetic analysis of HLA- and HPA-typing in idiopathic (autoimmune) thrombocytopenic purpura patients treated with cepharanthin.Effects of a novel pyridylsulphonyl thiazole derivative, FR115092, on autoimmune and mitomycin C-induced thrombocytopenia in mice.Induction of microthrombotic thrombocytopenia in normal mice by transferring a platelet-reactive, monoclonal anti-gp70 autoantibody established from MRL/lpr mice: an autoimmune model of thrombotic thrombocytopenic purpura.Anti-glycoprotein IIb/IIIa autoantibodies are reversibly internalized into platelets in idiopathic (autoimmune) thrombocytopenic purpura.A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy.Rapid platelet turnover in WASP(-) mice correlates with increased ex vivo phagocytosis of opsonized WASP(-) platelets.Prevention of murine antiphospholipid syndrome by BAFF blockadeDifferences between newborn and adult mice in their response to immune thrombocytopenia.Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.Crosstalk between Platelets and the Immune System: Old Systems with New DiscoveriesCytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on the mouse strain.Mouse Models for Immune-Mediated Platelet Destruction or Immune Thrombocytopenia (ITP).Assessment of Th17/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model.Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopeniaCalorie restriction prevents the occlusive coronary vascular disease of autoimmune (NZW x BXSB)F1 miceAutoimmune-prone (NZW x BXSB)F1 (W/BF1) mice escape severe thrombocytopenia after treatment with deoxyspergualin, an immunosuppressant.HLA and HPA typing in idiopathic thrombocytopenic purpura patients treated with Kami-kihi-to.Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cellsLessons from BXSB and related mouse models.Pathophysiology of the antiphospholipid antibody syndrome.Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice.Prevention of autoimmune inflammatory polyarthritis in male New Zealand black/KN mice by transplantation of bone marrow cells plus bone (stromal cells).Stem cell transplantation for autoimmune diseases: what can we learn from experimental models?Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+mice.Anticardiolipin antibodies in NZW x BXSB F1 mice.Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity.Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder.Cellular immunology in a historical perspective.Hypertension and diabetes mellitus increase the risk of haemorrhage in chronic idiopathic thrombocytopenic purpura.High mortality rate of (NZW x BXSB)F1 mice induced by administration of lipopolysaccharide attributes to high production of tumour necrosis factor-alpha by increased numbers of dendritic cells.
P2860
Q30929503-A7128173-32D3-42BE-A7C4-564630368FA3Q33329653-787B210B-E4FE-41E7-BFE3-194D94529A05Q33329887-DC20B4C5-F824-4E15-9729-47E5A8F5C164Q33331009-EB16353D-C63B-4604-AF60-C0FB55617C39Q33358161-DE24DF36-C1E6-4311-B542-58F62C21CBD7Q33369379-95D06A03-312B-4B44-8CEE-D59B1377B156Q33378989-4A4595C9-BA11-4D50-80A6-1E3DA1D204EEQ33380975-347BB3A4-D762-41C5-857F-00EC6A3F4770Q33388137-C2AEE35A-892A-4CA1-B58C-250FF31B2E4EQ33394044-498D3209-3C81-4703-8357-FACAB0101902Q33403517-EF70AF75-DE69-41D2-8254-3A4C92F227C7Q33415298-F325E0D7-F5D8-49F9-B51F-B60E0BB6590AQ33431172-F18A30ED-CC26-48A7-821A-CBA5B605F700Q33440206-FE8D6123-60CD-4251-8735-503717F3199FQ33440427-45830CF1-D479-416F-82A5-225A1D1A1D88Q33492697-8B409A79-E506-4543-B535-092ED3ED9D66Q33495166-F51B7EF6-05EB-499E-8B6F-96C8B828C72AQ33504141-E607C273-4C51-4FD1-8E91-76C9EAD55989Q33865273-08EB4214-A93A-4311-ADF2-6C1CE638D397Q34052004-01D8FA67-9518-4953-B5FE-CB2948F22CD1Q35309024-2350C5B3-0A8F-4BC8-A5F6-5E90AF81A52FQ36231911-0E52C126-AF55-49C2-8D8A-D8AB015C5C7BQ36776448-64943F97-8B61-4CF7-AE20-F64939F493D9Q37311085-20B7D5D8-5D32-4E84-A5A4-D0E5F8CA2805Q37410371-5DCB3E02-2417-4250-98BE-FFDD5A9CFDDBQ40558488-57B19B20-C708-419B-8D4B-E7FD5ECCF5E4Q41375825-CC67B9D0-F675-4F3A-8366-3D0A418A3AB0Q42821487-06DDA42B-A3AA-478C-922A-0F284E4F31F1Q51843846-2CC5B1C4-0956-4026-9CA8-C42DAFF5B48CQ54217089-FBED1826-BE32-4571-980A-B674B7846A04Q54516556-2B6984E9-21DE-4A52-97A0-3746B9439B31
P2860
(NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura.
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
name
(NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura.
@ast
(NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura.
@en
type
label
(NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura.
@ast
(NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura.
@en
prefLabel
(NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura.
@ast
(NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura.
@en
P2093
P2860
P356
P1476
(NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura.
@en
P2093
K Yasunaga
M Miyama-Inaba
R Yasumizu
S Mitsuoka
S Miyawaki
P2860
P304
P356
10.1084/JEM.167.6.2017
P407
P577
1988-06-01T00:00:00Z